BTAI vs RUN · rev $388.0K vs P/E 6.0, rev $1.59B
BioXcel Therapeutics Inc (BTAI) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported RUN revenue for 2026-06-30 was $1.59B. Net income was $282.8M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
BTAI currently screens at market cap $36.1M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the BTAI and RUN stock pages for the full models.
Not investment advice.